Diseases, Conditions, Syndromes

COVID-19 survivors might need just one dose of two-part vaccine

A single dose of the Pfizer-BioNTech vaccine for individuals who previously had COVID-19 generates an immunologic response similar to that of individuals receiving the two-dose recommended sequence, according to a Cedars-Sinai ...

Diseases, Conditions, Syndromes

Targeting a new antibody supersite key to COVID immunity

Scientists are learning that a lesser-studied region on the pandemic coronavirus is recognized by COVID-19 infection-fighting antibodies. These antibodies were identified in blood samples from previously infected patients, ...

Diseases, Conditions, Syndromes

New insight into antibody-induced protective immunity to COVID-19

While PCR testing has been used widely for COVID-19 diagnosis, it only provides information on who is currently infected. Antibody testing can tell who has been previously exposed to SARS-CoV-2, the virus that causes COVID-19, ...

Diseases, Conditions, Syndromes

Mapping an effective immune response to COVID-19

Melbourne researchers have systematically mapped the immune response to COVID-19 identifying how antibodies develop in response to SARS-CoV2 and new insights into why some people develop severe disease.

Diseases, Conditions, Syndromes

Antibody highs and lows in survivors of Ebola

A high proportion of survivors of Ebola experienced a resurgence in antibody levels nearly a year after recovery, a new University of Liverpool study has found.

page 9 from 40